发明名称 |
Method for Producing Haemophilus Influenzae Type B Antigens |
摘要 |
The invention concerns a method for producing, on an industrial scale, capsular polysaccharide of Haemophilus influenzae type b (PRP) intended for vaccine purposes, according to which a strain of Haemophilus influenzae type b (Hib) is cultured in a culture medium, the culture supernatant is harvested and treated in order to extract the capsular polysaccharide therefrom, said culture medium comprising at least: —one source of carbon, —protoporphyrin, —salts, —amino acids, —NAD or NADH, —vitamins, —means for regulating the pH, characterised in that said culture medium is chemically defined. |
申请公布号 |
US2015167036(A1) |
申请公布日期 |
2015.06.18 |
申请号 |
US201314411241 |
申请日期 |
2013.07.02 |
申请人 |
Sanofi Pasteur |
发明人 |
Le Hir Jérome;Loubiere Pascal;Barbirato Fabien;Lindley Nicholas |
分类号 |
C12P19/04;A61K39/102 |
主分类号 |
C12P19/04 |
代理机构 |
|
代理人 |
|
主权项 |
1. A process for producing, on an industrial scale, capsular polysaccharide of Haemophilus influenzae type b (PRP) suitable for use in a vaccine, the process comprising culturing a strain of Haemophilus influenzae type b (Hib) in a culture medium, and harvesting and treating the culture supernatant to extract the capsular polysaccharide therefrom, said culture medium comprising at least:
a source of carbon, protoporphyrin, salts, amino acids, NAD or NADH, vitamins, pH-regulating means,wherein said culture medium is chemically defined, and comprises at least zinc. |
地址 |
Lyon cedex 07 FR |